Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

被引：0
|
作者：
Rosanna Di Paola
Salvatore Cuzzocrea
机构：
[1] University of Messina,Department of Clinical and Experimental Medicine and Pharmacology, School of Medicine
[2] Torre Biologica-Policlinico Universitario,undefined
[3] IRCCS Centro Neurolesi Bonino-Pulejo,undefined
来源：
Naunyn-Schmiedeberg's Archives of Pharmacology | 2007年 / 375卷
关键词：
Peroxisome proliferator-activated receptors; Ischemia; Reperfusion tissue injury;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Peroxisome proliferator-activated receptors (PPARs) belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: α, β/δ and γ, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes like regulation of glucose and lipid redistribution. They also have anti-atherogenic, anti-inflammatory as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with ischemia and reperfusion. The potential utility of PPAR ligands in ischemia and reperfusion will be discussed in this review.
引用
收藏
页码：157 / 175
页数：18
相关论文
共 50 条
  • [1] Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury
    Di Paola, Rosanna
    Cuzzocrea, Salvatore
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 (03) : 157 - 175
  • [2] Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury
    Cuzzocrea, S
    VASCULAR PHARMACOLOGY, 2004, 41 (06) : 187 - 195
  • [3] Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats
    Cao, Zeling
    Ye, Ping
    Long, Chaoliang
    Chen, Kai
    Li, Xiaowei
    Wang, Hai
    PHARMACOLOGY, 2007, 79 (03) : 184 - 192
  • [4] Activation of peroxisome proliferator-activated receptor-α protects the heart from ischemia/reperfusion injury
    Yue, TL
    Bao, W
    Jucker, BM
    Gu, JL
    Romanic, AM
    Brown, PJ
    Cui, JQ
    Thudium, DT
    Boyce, R
    Burns-Kurtis, CL
    Mirabile, RC
    Aravindhan, K
    Ohlstein, EH
    CIRCULATION, 2003, 108 (19) : 2393 - 2399
  • [5] Sildenafil obviates ischemia-reperfusion injury-induced acute kidney injury through peroxisome proliferator-activated receptor γ agonism in rats
    Mohey, Vinita
    Singh, Manjinder
    Puri, Nikkita
    Kaur, Tajpreet
    Pathak, Devendra
    Singh, Amrit Pal
    JOURNAL OF SURGICAL RESEARCH, 2016, 201 (01) : 69 - 75
  • [6] Peroxisome proliferator-activated receptors for hypertension
    Usuda, Daisuke
    Kanda, Tsugiyasu
    WORLD JOURNAL OF CARDIOLOGY, 2014, 6 (08): : 744 - 754
  • [7] Peroxisome proliferator-activated receptors and their functions
    Jiao, HL
    Ye, P
    Zhao, BL
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2001, 28 (04) : 478 - 481
  • [8] Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors
    Lee, T-I.
    Kao, Y-H.
    Chen, Y-C.
    Chen, Y-J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (01) : 23 - 30
  • [9] The role of various peroxisome proliferator-activated receptors and their ligands in clinical practice
    Derosa, Giuseppe
    Sahebkar, Amirhossein
    Maffioli, Pamela
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (01) : 153 - 161
  • [10] Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (08) : 943 - 959
12345